Related Experiment Video
Updated: Sep 18, 2025
Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
Association between Nucleoside and Nucleotide Reverse Transcriptase Inhibitor Use and Primary Open-Angle Glaucoma
Kenneth Pham1, Fangming Jin2, Roy Lee1
1Penn Medicine Center for Genetics of Complex Disease, Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania.
Purpose:
To assess the association between the systemic use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) and primary open-angle glaucoma (POAG).
Design:
Retrospective cohort study.
Participants:
Individuals aged ≥40 years with linked electronic health record (EHR) data in the National Institutes of Health (NIH) All of Us dataset. Participants with a diagnosis of POAG before the use of NRTIs were excluded.
Methods:
A cohort of 1:10 NRTI users to nonusers was created using a propensity score matching design, considering age, race, sex at birth, human immunodeficiency virus (HIV) diagnosis, hepatitis B diagnosis, and family history of POAG. A multivariable logistic regression model was used to adjust for residual imbalance. Sensitivity analyses were performed for self-reported eye doctor visits.
Main Outcome Measure:
Diagnosis of POAG.
Results:
Among the 305 441 All of Us participants aged ≥40 years with a linked EHR, we identified 718 individuals (0.24%) with NRTI use, excluding participants with a diagnosis of POAG before NRTI exposure. The rate of POAG in the NRTI users was 4.32% (N = 31). The rate of POAG in the propensity score-matched control group (N = 7180) was 2.00% (N = 144). Use of NRTI was associated with an increased risk of POAG (odds ratio [OR], 2.21; 95% confidence interval [CI], 1.48-3.28; P < 0.001). When adjusting for residual imbalance of family history of POAG, HIV diagnosis, and hepatitis B diagnosis, use of any NRTIs remained significantly associated with an increased risk of developing POAG (OR, 1.84; 95% CI, 1.22-2.77; P = 0.004). After matching and adjusting for self-reported eye doctor visits, NRTIs remained significantly associated with POAG risk (OR, 2.30; 95% CI, 1.07-4.96; P = 0.033).
Conclusions:
Use of NRTIs was associated with a higher risk of POAG with propensity score matching for covariates and adjusting for residual imbalances.
Financial Disclosure(S):
The author(s) have no proprietary or commercial interest in any materials discussed in this article.
More Related Videos
07:11Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:25Glaucoma: Overview
01:28Angle Closure Glaucoma: Treatment
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones